LKL International Berhad 将来の成長

Future 基準チェック /06

We currently don't have sufficient analyst coverage to forecast growth and revenue for LKL International Berhad.

主要情報

n/a

収益成長率

n/a

EPS成長率

Medical Equipment 収益成長	23.0%
収益成長率	n/a
将来の株主資本利益率	n/a
アナリストカバレッジ	None
最終更新日	n/a

今後の成長に関する最新情報

更新なし

Recent updates

Is LKL International Berhad (KLSE:LKL) Using Too Much Debt?

Oct 07

Investors Aren't Entirely Convinced By LKL International Berhad's (KLSE:LKL) Revenues

Jun 14

Is LKL International Berhad (KLSE:LKL) Weighed On By Its Debt Load?

Mar 29

We're Watching These Trends At LKL International Berhad (KLSE:LKL)

Feb 14

What Type Of Shareholders Own The Most Number of LKL International Berhad (KLSE:LKL) Shares?

Jan 10

LKL International Berhad (KLSE:LKL) Could Easily Take On More Debt

Dec 14

If You Had Bought LKL International Berhad (KLSE:LKL) Stock A Year Ago, You Could Pocket A 773% Gain Today

Nov 27

Should You Be Impressed By LKL International Berhad's (KLSE:LKL) Returns on Capital?

Aug 03

Should You Use LKL International Berhad's (KLSE:LKL) Statutory Earnings To Analyse It?

Jul 08

このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、LKL International Berhad は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。

シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。

業績と収益の成長予測

KLSE:LKL - アナリストの将来予測と過去の財務データ ( )MYR Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
6/30/2024	44	-9	-15	12	N/A
3/31/2024	44	-14	-33	-4	N/A
12/31/2023	45	-7	-42	-16	N/A
12/31/2022	82	-16	-21	-6	N/A
9/30/2021	53	-36	-31	-22	N/A
4/30/2021	50	-3	-32	-21	N/A
1/31/2021	62	3	-14	-5	N/A
10/31/2020	64	4	4	5	N/A
7/31/2020	65	5	4	6	N/A
4/30/2020	55	4	-9	-7	N/A
1/31/2020	42	-2	2	4	N/A
10/31/2019	40	-2	1	3	N/A
7/31/2019	39	-2	1	2	N/A
4/30/2019	37	-2	0	1	N/A
1/31/2019	36	-1	-1	0	N/A
10/31/2018	35	0	-3	-2	N/A
7/31/2018	33	0	-6	-3	N/A
4/30/2018	30	-1	N/A	-2	N/A
1/31/2018	28	1	N/A	-1	N/A
10/31/2017	25	1	N/A	-3	N/A
7/31/2017	27	2	N/A	1	N/A
4/30/2017	34	4	N/A	2	N/A
1/31/2017	37	3	N/A	-1	N/A
10/31/2016	42	5	N/A	6	N/A
7/31/2016	41	4	N/A	7	N/A
4/30/2016	37	3	N/A	7	N/A
1/31/2016	41	6	N/A	10	N/A
10/31/2015	43	6	N/A	5	N/A
7/31/2015	41	6	N/A	6	N/A
4/30/2015	39	6	N/A	7	N/A
4/30/2014	39	6	N/A	9	N/A

アナリストによる今後の成長予測

収入対貯蓄率: Insufficient data to determine if LKL's forecast earnings growth is above the savings rate (3.6%).

収益対市場: Insufficient data to determine if LKL's earnings are forecast to grow faster than the MY market

高成長収益: Insufficient data to determine if LKL's earnings are expected to grow significantly over the next 3 years.

収益対市場: Insufficient data to determine if LKL's revenue is forecast to grow faster than the MY market.

高い収益成長: Insufficient data to determine if LKL's revenue is forecast to grow faster than 20% per year.

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: Insufficient data to determine if LKL's Return on Equity is forecast to be high in 3 years time

LKL International Berhad 将来の成長

Future 基準チェック /06

主要情報

今後の成長に関する最新情報

Recent updates

Is LKL International Berhad (KLSE:LKL) Using Too Much Debt?

Second quarter 2024 earnings released: RM0.006 loss per share (vs RM0.22 loss in 2Q 2023)

New major risk - Market cap size

LKL International Berhad Appoints Lim Pak Hong as Executive Director

First quarter 2024 earnings released: RM0.019 loss per share (vs RM0.22 loss in 1Q 2023)

New minor risk - Financial position

LKL International Berhad Announces Resignation of Datuk Chong Loong Men as Executive Director

LKL International Berhad, Annual General Meeting, May 30, 2024

Full year 2023 earnings released: RM0.022 loss per share (vs RM0.18 loss in FY 2022)

New major risk - Market cap size

New minor risk - Financial data availability

New minor risk - Share price stability

New minor risk - Share price stability

Investors Aren't Entirely Convinced By LKL International Berhad's (KLSE:LKL) Revenues

LKL International Berhad Appoints Haji Mohd Yazid Bin Haji Mustafa as Independent and Non Executive Chairman

LKL International Berhad Appoints Winnie Goh Kah Mun as Joint Secretary

Is LKL International Berhad (KLSE:LKL) Weighed On By Its Debt Load?

LKL International Berhad Announces Resignation of Miss Sia Su Lin as Chief Financial Officer

High number of new and inexperienced directors

LKL International Berhad Announces Resignation of Mr. Tay Ben Seng, Benson as Executive Director, with Effect from May 30, 2022

Lkl International Berhad Announces Redesignation of Lim Ming Chang from Executive Director to Non Independent and Non Executive Director

Less than half of directors are independent

LKL International Berhad Reports Impairment Losses for the First Quarter Ended December 31, 2021

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

LKL International Berhad, Annual General Meeting, Mar 15, 2022

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Financial Controller Chuen Wee has left the company

Full year 2021 earnings released: RM0.008 loss per share (vs RM0.01 profit in FY 2020)

Independent & Non-Executive Chairman Chaw Chen has left the company

Independent Non-Executive Director has left the company

LKL International Berhad Appoints Dato' Seri Dr. Chen Chaw Min as Independent and Non Executive Non Executive Chairman

New 90-day low: RM0.74

We're Watching These Trends At LKL International Berhad (KLSE:LKL)

New 90-day low: RM0.83

What Type Of Shareholders Own The Most Number of LKL International Berhad (KLSE:LKL) Shares?

Second quarter 2021 earnings released: RM0.002 loss per share

LKL International Berhad (KLSE:LKL) Could Easily Take On More Debt

New 90-day low: RM0.91

If You Had Bought LKL International Berhad (KLSE:LKL) Stock A Year Ago, You Could Pocket A 773% Gain Today

LKL International Berhad Appoints Lim Ming Chang as Executive Director

LKL International Berhad Appoints Datuk Chong Loong Men as Independent and Non Executive Member of Nomination Committee

Lkl International Berhad Announces Cessation of Tan Sri Datuk Adzmi Bin Abdul Wahab as Independent and Non Executive Member of Risk Committee

LKL International Berhad (KLSE:LKL) agreed to acquire 60% stake in Tahmaz Meditech Sdn Bhd from Ahmad Izhan Bin Abd Rashid, Andrew Suriady Sjoekoer, Chong Mei Ling, and Goventamal A/P Vadivelu.